Evidence map›Paper›PMID 29867487›Full record

ArticleFrontiers in pharmacology2018

Betulinic Acid Exerts Cytotoxic Activity Against Multidrug-Resistant Tumor Cells via Targeting Autocrine Motility Factor Receptor (AMFR).

Mohamed E M Saeed, Nuha Mahmoud, Yoshikazu Sugimoto, Thomas Efferth, Heba Abdel-Aziz

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 49 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. GC-MS/MS Quantification of EGFR Inhibitors,Molecules (Basel, Switzerland) · 2022
    Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Differential Cytotoxic Potential ofMolecules (Basel, Switzerland) · 2019
    Article
  19. Article
  20. Cytotoxicity of Crude Extract and Isolated Constituents of theEvidence-based complementary and alternative medicine : eCAM · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Mohamed E M SaeedDepartment of Pharmaceutical Biology, Johannes Gutenberg University, Mainz, Germany.
Nuha MahmoudDepartment of Pharmaceutical Biology, Johannes Gutenberg University, Mainz, Germany.
Yoshikazu SugimotoDivision of Chemotherapy, Faculty of Pharmacy, Keio University, Tokyo, Japan.
Thomas EfferthDepartment of Pharmaceutical Biology, Johannes Gutenberg University, Mainz, Germany.
Heba Abdel-AzizMedical and Clinical Affairs Phytomedicines, Steigerwald Arzneimittelwerk GmbH, Bayer Consumer Health, Darmstadt, Germany.
Johannes Gutenberg University Mainz · DEBayer (Germany) · DEKeio University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Betulinic acid (BetA) is a naturally occurring pentacyclic triterpene isolated from the outer bark of white-barked birch trees and many other medicinal plants. Here, we studied betulinic acid's cytotoxic activity against drug-resistant tumor cell lines. P-glycoprotein (

Indexed as

autocrine motility factor receptor (AMFR)bioinformaticscancerdrug resistancemicroarraypharmacogenomicsphytotherapytriterpene

Identifiers

PMID29867487
PMCPMC5962668
OpenAlexW2800837449

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.